Crossref

1. Progress in research on association between cell signal transduction pathways and hepatocellular carcinoma

- Chun Chen

- Zhe Yang

- Zan-Song Huang

2. Is the Expression of p53, c-<italic>erb</italic>-B2 and Ki-67 Influence the Prognosis of the Non-muscle Invasive Urothelial Bladder Cancer?

- Seok Hyun Kang

- Hyun Jin Jung

- Eun Kyoung Yang

- Jae Shin Park

- Hoon Kyu Oh

- Duk Yoon Kim

3. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine

- Hala Fawzy Mohamed Kamel

- Hiba Saeed A. Bagader Al-Amodi

4. Genomic biomarkers to guide precision radiotherapy in prostate cancer

- Philip Sutera

- Matthew P. Deek

- Kim Van der Eecken

- Alexander W. Wyatt

- Amar U. Kishan

- Jason K. Molitoris

- Matthew J. Ferris

- M. Minhaj Siddiqui

- Zaker Rana

- Mark V. Mishra

- Young Kwok

- Elai Davicioni

- Daniel E. Spratt

- Piet Ost

- Felix Y. Feng

- Phuoc T. Tran

5.

6. Genetic alterations in hepatocellular carcinoma: An update

- Zhao-Shan Niu

- Xiao-Jun Niu

- Wen-Hong Wang

7. Marsdenia tenacissima Extract Induces Autophagy and Apoptosis of Hepatocellular Cells via MIF/mToR Signaling

- Shuai Lin

- Qianwen Sheng

- Xiaobin Ma

- Shanli Li

- Peng Xu

- Cong Dai

- Meng Wang

- Huafeng Kang

- Zhijun Dai

- Yoshiki Mukudai

8. SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma

- Andrew X. Zhu

- Olivier Rosmorduc

- T.R. Jeffry Evans

- Paul J. Ross

- Armando Santoro

- Flair Jose Carrilho

- Jordi Bruix

- Shukui Qin

- Paul J. Thuluvath

- Josep M. Llovet

- Marie-Aude Leberre

- Markus Jensen

- Gerold Meinhardt

- Yoon-Koo Kang

9. Precise Immunodetection of PTEN Protein in Human Neoplasia

- Rafael Pulido

- Janire Mingo

- Ayman Gaafar

- Caroline E. Nunes-Xavier

- Sandra Luna

- Leire Torices

- Javier C. Angulo

- José I. López

10. Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges

- Monica A. Kamal

- Yasmine M. Mandour

- Mostafa K. Abd El-Aziz

- Ulrike Stein

- Hend M. El Tayebi

11. miR-183-5p Promotes HCC Migration/Invasion via Increasing Aerobic Glycolysis

- Yaqian Niu

- Fang Liu

- Xiuyue Wang

- Yuling Chang

- Yanmei Song

- Huiyuan Chu

- Shisan Bao

- Che Chen

12. Evolving Systemic Therapy in Hepatocellular Carcinoma: Current Management and Opportunities for Integration With Radiotherapy

- Florence K. Keane

- Theodore S. Hong

- Andrew X. Zhu

13. Ecto‐5′‐nucleotidase (CD73) is a potential target of hepatocellular carcinoma

- Shalaimaiti Shali

- Jiangang Yu

- Xin Zhang

- Xue Wang

- Youping Jin

- Minsheng Su

- Xiaohong Liao

- Jerry Yu

- Xiuling Zhi

- Ping Zhou

14. Relationship between EGFR expression and subcellular localization with cancer development and clinical outcome

- Ge Yan

- Mohamed E.M. Saeed

- Sebastian Foersch

- Jose Schneider

- Wilfried Roth

- Thomas Efferth

15.

16. Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems

- Jing-Jun Yan

- Jia-Zhi Liao

- Ju-Sheng Lin

- Xing-Xing He

17. Expression and significance of the novel tumor-suppressor gene SMG-1 in hepatocellular carcinoma

- LI-LI HAN

- HAO-CHENG NAN

- TAO TIAN

- HUI GUO

- TING-HUA HU

- WEN-JUAN WANG

- JIE-QUN MA

- LI-LI JIANG

- QIAN-QIAN GUO

- CHENG-CHENG YANG

- XIAO-MIN KANG

- YING LIU

- YUAN GAO

- QI-LUN LIU

- KE-JUN NAN

18. A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma

- Melanie B. Thomas

- Elizabeth Garrett-Mayer

- Munazza Anis

- Kate Anderton

- Tricia Bentz

- Andie Edwards

- Alan Brisendine

- Geoffrey Weiss

- Abby B. Siegel

- Johanna Bendell

- Ari Baron

- Vinay Duddalwar

- Anthony El-Khoueiry

19. Different Faces of Hepatocellular Carcinoma as a Health Threat in 21st Century

- Behzad Yeganeh

- Mohammad Hashemi

- Fredrick J. de Serres

- Marek J. Los

- Saeid Ghavami

20. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells

- Dali Zhao

- Bo Zhai

- Changjun He

- Gang Tan

- Xian Jiang

- Shangha Pan

- Xuesong Dong

- Zheng Wei

- Lixin Ma

- Haiquan Qiao

- Hongchi Jiang

- Xueying Sun

21. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization

- Xu-Cai Wang

- Fan Wang

- Qing-Qing Quan

22. EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma

- Chuangye Han

- Xiwen Liao

- Wei Qin

- Long Yu

- Xiaoguang Liu

- Gang Chen

- Zhengtao Liu

- Sicong Lu

- Zhiwei Chen

- Hao Su

- Guangzhi Zhu

- Zili Lu

- Zhiming Liu

- Xue Qin

- Ying Gui

- Zengnan Mo

- Lequn Li

- Tao Peng